Abstract | BACKGROUND: AIM: MATERIALS AND METHODS: Twenty-six patients with an active episode of pouchitis (defined as a pouchitis disease activity index score >or= 7) and no treatment during the previous month were randomized to receive either budesonide enema (2 mg/100 mL at bedtime) plus placebo tablets or oral metronidazole (0.5 g b.d.) plus placebo enema in a prospective, double-blind, double-dummy, 6-week, controlled trial. RESULTS: Based on the intention-to-treat principle, we detected a significant improvement in disease activity at the end of the first week with both drugs (P < 0.01). After that, improvement was moderated until stabilization at 4 weeks in both treatments. The per protocol analysis showed that both drugs had similar efficacy in terms of disease activity, clinical and endoscopic findings. Fifty-eight per cent and 50% of patients improved (decrease in pouchitis disease activity index >or= 3) with budesonide enema and metronidazole, respectively (odds ratio, 1.4; confidence interval, 0.2-8.9). Adverse effects were observed in 57% of patients given metronidazole and in 25% of patients given budesonide. CONCLUSIONS:
|
Authors | A Sambuelli, L Boerr, S Negreira, A Gil, G Camartino, S Huernos, Z Kogan, A Cabanne, A Graziano, H Peredo, I Doldán, O Gonzalez, E Sugai, M Lumi, J C Bai |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 16
Issue 1
Pg. 27-34
(Jan 2002)
ISSN: 0269-2813 [Print] England |
PMID | 11856075
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents
- Anti-Inflammatory Agents
- Metronidazole
- Budesonide
|
Topics |
- Administration, Oral
- Adolescent
- Adult
- Anti-Infective Agents
(administration & dosage, adverse effects, pharmacology)
- Anti-Inflammatory Agents
(administration & dosage, adverse effects, pharmacology)
- Budesonide
(administration & dosage, adverse effects, pharmacology)
- Double-Blind Method
- Enema
- Female
- Humans
- Male
- Metronidazole
(administration & dosage, adverse effects, pharmacology)
- Middle Aged
- Pouchitis
(drug therapy)
- Treatment Outcome
|